These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The regulation, localization, and functions of oxygen-sensing prolyl hydroxylase PHD3. Jaakkola PM; Rantanen K Biol Chem; 2013 Apr; 394(4):449-57. PubMed ID: 23380539 [TBL] [Abstract][Full Text] [Related]
4. PHD1 interacts with ATF4 and negatively regulates its transcriptional activity without prolyl hydroxylation. Hiwatashi Y; Kanno K; Takasaki C; Goryo K; Sato T; Torii S; Sogawa K; Yasumoto K Exp Cell Res; 2011 Dec; 317(20):2789-99. PubMed ID: 21951999 [TBL] [Abstract][Full Text] [Related]
5. The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin. Masson N; Appelhoff RJ; Tuckerman JR; Tian YM; Demol H; Puype M; Vandekerckhove J; Ratcliffe PJ; Pugh CW FEBS Lett; 2004 Jul; 570(1-3):166-70. PubMed ID: 15251459 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factors in the first trimester human lung. Groenman F; Rutter M; Caniggia I; Tibboel D; Post M J Histochem Cytochem; 2007 Apr; 55(4):355-63. PubMed ID: 17189520 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II differentially regulates Morg1 expression in kidney cells. Bondeva T; Heinzig J; Franke S; Wolf G Am J Nephrol; 2012; 35(5):442-55. PubMed ID: 22555025 [TBL] [Abstract][Full Text] [Related]
8. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors. Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia-induced assembly of prolyl hydroxylase PHD3 into complexes: implications for its activity and susceptibility for degradation by the E3 ligase Siah2. Nakayama K; Gazdoiu S; Abraham R; Pan ZQ; Ronai Z Biochem J; 2007 Jan; 401(1):217-26. PubMed ID: 16958618 [TBL] [Abstract][Full Text] [Related]
10. The novel WD-repeat protein Morg1 acts as a molecular scaffold for hypoxia-inducible factor prolyl hydroxylase 3 (PHD3). Hopfer U; Hopfer H; Jablonski K; Stahl RA; Wolf G J Biol Chem; 2006 Mar; 281(13):8645-55. PubMed ID: 16407229 [TBL] [Abstract][Full Text] [Related]
12. Prolyl-hydroxylase PHD3 interacts with pyruvate dehydrogenase (PDH)-E1β and regulates the cellular PDH activity. Kikuchi D; Minamishima YA; Nakayama K Biochem Biophys Res Commun; 2014 Aug; 451(2):288-94. PubMed ID: 25088999 [TBL] [Abstract][Full Text] [Related]
13. Human PRP19 interacts with prolyl-hydroxylase PHD3 and inhibits cell death in hypoxia. Sato M; Sakota M; Nakayama K Exp Cell Res; 2010 Oct; 316(17):2871-82. PubMed ID: 20599946 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia inducible prolyl hydroxylase PHD3 maintains carcinoma cell growth by decreasing the stability of p27. Högel H; Miikkulainen P; Bino L; Jaakkola PM Mol Cancer; 2015 Jul; 14():143. PubMed ID: 26223520 [TBL] [Abstract][Full Text] [Related]
15. Autophagy activation clears ELAVL1/HuR-mediated accumulation of SQSTM1/p62 during proteasomal inhibition in human retinal pigment epithelial cells. Viiri J; Amadio M; Marchesi N; Hyttinen JM; Kivinen N; Sironen R; Rilla K; Akhtar S; Provenzani A; D'Agostino VG; Govoni S; Pascale A; Agostini H; Petrovski G; Salminen A; Kaarniranta K PLoS One; 2013; 8(7):e69563. PubMed ID: 23922739 [TBL] [Abstract][Full Text] [Related]
16. p62 degradation by autophagy: another way for cancer cells to survive under hypoxia. Jaakkola PM; Pursiheimo JP Autophagy; 2009 Apr; 5(3):410-2. PubMed ID: 19197142 [TBL] [Abstract][Full Text] [Related]
17. Autophagic degradation of the androgen receptor mediated by increased phosphorylation of p62 suppresses apoptosis in hypoxia. Mitani T; Minami M; Harada N; Ashida H; Yamaji R Cell Signal; 2015 Oct; 27(10):1994-2001. PubMed ID: 26186973 [TBL] [Abstract][Full Text] [Related]
18. PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer. Su Y; Loos M; Giese N; Hines OJ; Diebold I; Görlach A; Metzen E; Pastorekova S; Friess H; Büchler P Br J Cancer; 2010 Nov; 103(10):1571-9. PubMed ID: 20978507 [TBL] [Abstract][Full Text] [Related]